Caxton Associates (New York)’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q3
Sell
-3,431
Closed -$508K 295
2020
Q2
$508K Buy
+3,431
New +$508K 0.04% 122